Search the Newsreel

ClearPoint Neuro (CLPT) Stock Falls on Q2 2026 Earnings

ClearPoint Neuro, Inc. (CLPT) reported its Q2 2026 earnings, missing analyst expectations for both EPS and revenue. The company's cash reserves decreased, and it lowered its full-year 2026 revenue guidance to $48 million to $52 million. This performance is attributed to a pivot towards …

Coca-Cola Europacific Partners (NASDAQ: CCEP) details July 2026 share buybacks

ClearPoint Neuro (NASDAQ:CLPT) Issues Quarterly Earnings Results, Misses Estimates By $0.09 EPS

ClearPoint Neuro (Nasdaq: CLPT) lifts Q2 2026 revenue while net loss deepens

Is Neurocrine Biosciences (NBIX) A Bargain After Strong Q2 Results And Higher Guidance?

Neurocrine Biosciences (NBIX) reported strong Q2 2026 results and raised full-year INGREZZA sales guidance, yet its share price declined by about 10% on the day of the announcement, despite positive longer-term momentum. The stock is currently valued at $166.80, considered 13.5% undervalued by Simply …

Coca-Cola Europacific Partners Plc 1H Oper Pft EUR1.46B

Coca-Cola Europacific Partners Plc reported a 1H operating profit of EUR1.46 billion. This financial update provides key insights into the company's performance over the first half of the fiscal year.

Jupiter Neurosciences (JUNS) Stock Forecast & Analyst Ratings

This article provides a stock forecast and analyst ratings for Jupiter Neurosciences (JUNS). It likely covers aspects such as price targets, current recommendations from analysts, and potential future performance. Investors can use this information to inform their decisions regarding the stock.

Euroseas Stock Price Forecast. Should You Buy ESEA?

Euroseas Ltd. (ESEA) stock saw a -2.43% drop on August 5, 2026, marking its fourth consecutive daily fall. Despite this, StockInvest.us maintains a "Hold/Accumulate" rating with a technical score of -0.50, forecasting a 9.01% rise over the next three months. The company has strong …

NERV Q1 2026 Earnings: EPS Miss Widens Loss as Clinical-Stage Pipeline Burns Cash - Annual Earnings Summary

North European Oil Royalty Trust (NRT) Jumps 7.2% to $9.51, Approaching Key Resistance - Impulse Wave

ProMIS Neurosciences (PMN) Shares Drop 8% as Stock Tests Key Support Level - ETF AUM Growth

Coca-Cola Europacific Partners $CCEP Shares Purchased by Optiver Holding B.V.

NPCE Q1 2026 Earnings: Narrower Net Loss Beats Expectations as Shares Decline 6.25% - ROIC Trend Report

XBP Global Holdings, Inc. Revenue Breakdown – NASDAQ:XBP

This article provides a revenue breakdown for XBP Global Holdings, Inc. (NASDAQ:XBP). In the last fiscal year, the company generated $791.00 million USD in revenue, with the "Applied Workflow Automation" segment contributing the most at $723.21 million USD. The majority of this revenue, $712.75 …

Neuronetics’ Five New Hires Get RSUs Vesting Over 4 Years

Neuronetics (NASDAQ: STIM) has granted equity inducement awards in the form of restricted stock units (RSUs) to five new non-executive employees. These awards, made under the company's 2020 Inducement Incentive Plan and in accordance with Nasdaq Listing Rule 5635(c)(4), vest over three to four …

PMN|ProMIS Neurosciences Inc|Price:13.720|Chg%:-1.200

This article provides a comprehensive stock analysis of ProMIS Neurosciences Inc (PMN), highlighting its strong fundamentals and high growth potential. The company's valuation is considered fair, and institutional ownership is notably high. Analysts have issued "Buy" ratings, projecting a significant upside for the stock …

Neurocrine Biosciences (NBIX) Is Down 5.1% After Q2 Earnings Beat And Higher INGREZZA Guidance – What's Changed

In the second quarter of 2026, Neurocrine Biosciences reported revenue of US$959.0 million and net income of US$144.4 million, sharply higher than a year earlier and ahead of analyst expectations, with INGREZZA, CRENESSITY, and newly acquired VYKAT XR leading record sales. The company also …

Neurocrine Biosciences (NBIX) Appoints Four Senior Leaders As Pipeline And Portfolio Expand

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Neurocrine Biosciences appointed a new Chief Business Officer and three Senior Vice Presidents to its senior leadership team. The moves come as the company …

Janus Henderson Group PLC Buys 48,990 Shares of Euronet Worldwide, Inc. $EEFT

Janus Henderson Group PLC increased its stake in Euronet Worldwide, Inc. (NASDAQ:EEFT) by 3.6% in the first quarter, purchasing an additional 48,990 shares to bring its total holding to over 1.4 million shares valued at approximately $93.4 million. This move comes as other institutional …

Euronet Worldwide, Inc. (NASDAQ:EEFT) Receives Average Rating of "Hold" from Analysts

Euronet Worldwide (NASDAQ:EEFT) has an average "Hold" rating from analysts, with three recommending a buy, three a hold, and one a sell. The average 12-month price target is $96.00, significantly higher than its current share price of $71.33. The company's Q2 2026 results showed …

Coca-Cola Europacific Partners PLC (CCEP) Financial Health: Profitability & Balance Sheet Analysis

This article provides a financial health analysis of Coca-Cola Europacific Partners PLC (CCEP), ranking its current financial score at 7.37, which is 14th out of 24 in the Beverages industry. The analysis indicates the company has stable financial status and average operating efficiency. Key …

NGNE Q1 2026 Earnings: Wider-than-Expected Loss Dents Shares - Estimate Revision Count

Neurocrine Biosciences (NBIX) Stock Slides As Growth Spending Steals Focus

Neurocrine Biosciences (NBIX) stock dropped 10% despite strong Q2 2026 revenue and earnings, indicating the market is reacting to growth spending rather than current earnings. The company showed robust performance with INGREZZA and emerging products like CRENESSITY and VYKAT XR, but analysts are cautious …

NPCE Q1 2026 Earnings: Narrower Loss Beats Estimates by 14.75%, Yet Shares Slip 6.25% - Diluted EPS Report

B&M European Value Retail (LON:BME) Share Price Crosses Above 50-Day Moving Average - Here's What Happened

Neurocrine Biosciences (NBIX) Lifts INGREZZA Guidance, Is The Pullback A Bargain?

Eurobank S.A. 2026 Q2 - Results - Earnings Call Presentation (OTCMKTS:ERBKY) 2026-08-01

Euro India Fresh Foods Ltd. Revenue Breakdown – NSE:EIFFL

Neurogene Inc. Revenue Breakdown – NASDAQ:NGNE

Euronext Athens Holding S.A. Revenue Breakdown – ATHEX:EXAE

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Neuronetics, Inc. announced an inducement grant of restricted stock units (RSUs) to its new Chief Financial Officer, Matthew Bennett. This grant, totaling 167,490 RSUs, was made outside of the company's existing equity compensation plans but was approved by the Compensation Committee in accordance with …

Neurocrine Biosciences, Inc. Revenue Breakdown – NASDAQ:NBIX

Neurocrine Biosciences, Inc. (BX:NB3) reported a total revenue of 2.27 billion CHF last year, primarily driven by its Pharmaceuticals segment. The majority of this revenue, also 2.27 billion CHF, came from operations within the United States. This indicates a strong reliance on the pharmaceutical …

EUROBANK S.A. Revenue Breakdown – ATHEX:EUROB

Neuropace Inc (NPCE) Financial Health: Profitability & Balance Sheet Analysis

Neuropace Inc (NPCE) currently holds a financial score of 6.68, ranking 138 out of 200 in the Healthcare Equipment & Supplies industry, indicating a weak financial status and average operating efficiency. The company's latest quarterly revenue decreased by 2.02% year-over-year to $22.07M, with net …

European Metals advances Cinovec permitting and flags major cost savings

NeuroSense Therapeutics (NRSN) seeks reverse split amid Nasdaq compliance push

NeuroSense Therapeutics (NRSN) is calling a Special Meeting of Shareholders on August 26, 2026, to seek approval for a reverse stock split. This move is aimed at regaining compliance with Nasdaq's minimum bid price ($1.00) and market value of listed securities ($35 million) requirements, …